Evidence map›Paper›PMID 39723225›Full record

ArticlePhenomics (Cham, Switzerland)2024

Prognostic Significance of

Zhengxing Li, Yuewen Hu, Chang Xu, Zixiu Zou, Zhenyu Sun, Zhunyi Gao, Man Xiao, Shicheng Guo, Yi Wang, Haijian Wang and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Phenomics (Cham, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhengxing Li *Department of Surgery, Navy Military Medical University Affiliated to Changhai Hospital, Shanghai, 200433 China.ORCID 0009-0006-0724-5344
Yuewen Hu *Department of Outpatient, Chinese People's Liberation Army 92914 Army Hospital, Hainan, 571833 China.
Chang Xu *Clinical College of Xiangnan University, Chenzhou, 423000 China.
Zixiu ZouSchool of Life Sciences, Fudan University, Shanghai, 200438 China.
Zhenyu SunSchool of Basic Medicine, Navy Military Medical University, Shanghai, 200433 China.
Zhunyi GaoDepartment of Radiotherapy, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006 China.
Man XiaoDepartment of Biochemistry and Molecular Biology, Hainan Medical University, Haikou, 571199 China.
Shicheng GuoState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200438 China.
Yi WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200438 China.
Haijian WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200438 China.
Zhiping WangHealth Management Center, the First Affiliated Hospital of Navy Medical University, Shanghai, 200433 China.
Qiang LiDepartment of Respiratory and Critical Care Medicine, Shanghai East Hospital, TongJi University, Shanghai, 200120 China.
Bo ShenThe Affilated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, 42 Baiziting, Nanjing, Jiangsu 210009 China.ORCID 0000-0001-5709-5213
Yuanlin SongDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032 China.ORCID 0000-0003-3373-6631
Junjie WuDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032 China.ORCID 0000-0002-4000-7026

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains the leading cause of death among cancer patients, and the five-year survival rate is less than 25%. However, Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-024-00171-z.

Indexed as

Lung cancerMethyl-CpG Binding Domain4PolymorphismPrognosisrs140693

Identifiers

PMID39723225
PMCPMC11666875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.